Quantcast
Connect with us

Ex-hedge funder buys rights to AIDS drug and raises price from $13.50 to $750 per pill

Published

on

A former hedge fund manager turned pharmaceutical businessman has purchased the rights to a 62-year-old drug used for treating life-threatening parasitic infections and raised the price overnight from $13.50 per tablet to $750.

WATCH: Ex-hedge funder who hiked AIDS pill cost by 5,500 percent says drug ‘still underpriced’

According to the New York Times, Martin Shkreli, 32, the founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim for $55 million on the same day that Turing announced it had raised $90 million from Shkreli and other investors in its first round of financing.

ADVERTISEMENT

RELATED: These 37 tweets show how the pharma CEO gouging AIDS patients is even worse than you think

Daraprim is used for treating toxoplasmosis — an opportunistic parasitic infection that can cause serious or even life-threatening problems in babies and for people with compromised immune systems like AIDS patients and certain cancer patients — that sold for slightly over $1 a tablet several years ago.  Prices have increased as the rights to the drug have been passed from one pharmaceutical company to the next, but nothing like the almost 5,500 percent increase since Shkreli acquired it.

Worrying that the cost of treatment could devastate some patients, Dr. Judith Aberg, the chief of the division of infectious diseases at the Icahn School of Medicine at Mount Sinai asked, “What is it that they are doing differently that has led to this dramatic increase?”

According to Shkreli, Turing will use the money it earns to develop better treatments for toxoplasmosis, with fewer side effects.

“This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business,” Shkreli explained, saying that many patients use the drug for far less than a year and that the new price is similar to other drugs used for rare diseases.

ADVERTISEMENT

Shrkeli also defended his small pharmaceutical company saying, “It really doesn’t make sense to get any criticism for this.”

This is not the first time the fledgling pharmaceutical executive has come under scrutiny.

He started the hedge fund MSMB Capital while in his 20’s and was accused of urging the FDA to not approve certain drugs made by companies whose stock he was shorting.

ADVERTISEMENT

In 2011,  Shkreli helped form Retrophin, which also acquired old drugs and immediately raised their prices. Retrophin’s board fired Shkreli a year ago and has filed a complaint in Federal District Court, accusing him of using Retrophin as a personal fund to pay back angry investors in his hedge fund.

 As for Shrkeli’s claim that he will put the excess profits back into research, doctors say that isn’t needed in this case.

ADVERTISEMENT

“I certainly don’t think this is one of those diseases where we have been clamoring for better therapies,” said Dr. Wendy Armstrong, professor of infectious diseases at Emory University in Atlanta.

Tweet from Martin Shkreli’s Twitter account below:

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

‘Bulletproof from a pardon’: Fox News analyst says judge in Stone case just made things tough for Trump

Published

on

In the wake of Roger Stone's sentencing of 3.5 years in prison this Thursday, Fox News legal analyst Andrew Napolitano posited that U.S. District Judge Amy Berman Jackson's choice to go along with Attorney General Bill Barr's sentencing recommendation could have been an effort to pardon-proof the sentence from President Trump.

"[Jackson's] trying to make this bulletproof from a pardon," Napolitano said. "Because she went along exactly with what [Barr] requested."

Continue Reading

Breaking Banner

Adam Schiff sends signal that a Roger Stone pardon would be another impeachable offense

Published

on

Rep. Adam Schiff suggested that a presidential pardon for Roger Stone would be an impeachable offense.

Judge Amy Berman Jackson sentenced the longtime Republican operative to 40 months in prison, saying Stone had lied to Congress and threatened a witness to cover up possible wrongdoing by President Donald Trump -- and Schiff sent a warning against a pardon.

"Roger Stone was found guilty of lying to Congress and threatening a witness," Schiff tweeted.

Schiff, who led the impeachment inquiry and trial, agreed with Jackson -- whose language echoed the lawmaker's "corrupt scheme and cover-up" indictment during the Senate trial.

Continue Reading
 

Breaking Banner

WATCH: Roger Stone greeted with ‘Lock Him Up!’ chants after getting sentenced to 40 months

Published

on

Trump ally Roger Stone frequently led chants of "Lock her up!" about Hillary Clinton during the 2016 presidential campaign -- but on Thursday, the table decisively turned.

After Stone was sentenced to 40 months in prison for charges of perjury, witness tampering, and obstruction of justice, a crowd of people greeted the right-wing dirty trickster by chanting, "Lock him up!" outside the courthouse.

At least one supporter of President Donald Trump tried to get a "pardon" chant going, but they were drowned out by the louder "Lock him up" chants.

Watch the video below.

Continue Reading
 
 
close-image